PreMD actively seeks partnerships and research collaborations with other companies, organizations and educational and governmental institutions that will enhance our capabilities, clinical program and product pipeline.
We are proud to work with organizations such as The Cleveland Clinic Foundation, the U.S. National Cancer Institute’s Early Detection Research Network (EDRN), McMaster University, and AtheroGenics, Inc., among many others. |
Technology In-Licensing
 |
| We seek to in-license novel technologies that have been proven in principle and that complement PreMD’s strengths and strategic focus. To potential partners, PreMD offers the proven ability to complete commercial development of promising technologies, from designing and managing the necessary clinical trials to driving the regulatory process. This includes obtaining broad-based patent protection to preserve and enhance the value of each technology.
PreMD looks for technologies that:
- Address a significant, unmet medical need;
- Are adaptable to point-of-care or over-the-counter applications;
- Offer significant cost benefits to existing products;
- Have established evidence of efficacy in human trials; and
- Have strong intellectual property.
We encourage interested researchers to contact our Corporate Development team with potential opportunities.
|
Research Collaborations
|
PreMD continuously strives to forge new research collaborations with thought leaders and leading organizations that can help to accelerate our clinical program while advancing innovation in the field of predictive medicine. We have established successful relationships with governmental groups, private institutions and academics. If you are an innovator in the cardiovascular or cancer fields, our Scientific Affairs team wants to hear from you. |
Commercial Alliances
|
With a primary focus on product development and clinical programs, PreMD aims to out-license its products to major diagnostic, pharmaceutical and consumer goods companies for sales and marketing. We seek partners with well-developed sales forces targeted to laboratories, clinicians and over-the-counter (OTC) markets, supported by established distribution channels. PreMD retains an interest in the products it licenses, which may include royalties, milestone payments and revenue sharing. For more information about partnering opportunities, please contact our Corporate Development team.
|
